Correlation Between Spero Therapeutics and Processa Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Spero Therapeutics and Processa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spero Therapeutics and Processa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spero Therapeutics and Processa Pharmaceuticals, you can compare the effects of market volatilities on Spero Therapeutics and Processa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spero Therapeutics with a short position of Processa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spero Therapeutics and Processa Pharmaceuticals.
Diversification Opportunities for Spero Therapeutics and Processa Pharmaceuticals
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Spero and Processa is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Spero Therapeutics and Processa Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Processa Pharmaceuticals and Spero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spero Therapeutics are associated (or correlated) with Processa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Processa Pharmaceuticals has no effect on the direction of Spero Therapeutics i.e., Spero Therapeutics and Processa Pharmaceuticals go up and down completely randomly.
Pair Corralation between Spero Therapeutics and Processa Pharmaceuticals
Given the investment horizon of 90 days Spero Therapeutics is expected to generate 0.23 times more return on investment than Processa Pharmaceuticals. However, Spero Therapeutics is 4.41 times less risky than Processa Pharmaceuticals. It trades about -0.02 of its potential returns per unit of risk. Processa Pharmaceuticals is currently generating about -0.02 per unit of risk. If you would invest 138.00 in Spero Therapeutics on September 14, 2024 and sell it today you would lose (31.00) from holding Spero Therapeutics or give up 22.46% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 99.6% |
| Values | Daily Returns |
Spero Therapeutics vs. Processa Pharmaceuticals
Performance |
| Timeline |
| Spero Therapeutics |
| Processa Pharmaceuticals |
Spero Therapeutics and Processa Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Spero Therapeutics and Processa Pharmaceuticals
The main advantage of trading using opposite Spero Therapeutics and Processa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spero Therapeutics position performs unexpectedly, Processa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Processa Pharmaceuticals will offset losses from the drop in Processa Pharmaceuticals' long position.| Spero Therapeutics vs. Assembly Biosciences | Spero Therapeutics vs. Achilles Therapeutics PLC | Spero Therapeutics vs. Instil Bio | Spero Therapeutics vs. CytomX Therapeutics |
| Processa Pharmaceuticals vs. Alpha Cognition | Processa Pharmaceuticals vs. Acurx Pharmaceuticals LLC | Processa Pharmaceuticals vs. Fennec Pharmaceuticals | Processa Pharmaceuticals vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |